IRD vs TDG · rev $2.9M vs P/E 41, rev $8.83B
Opus Genetics, Inc. (IRD) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported IRD revenue for 2026-06-30 was $2.9M. Net income was -$73.6M. Revenue was up 35.0% from 2026-03-31 to 2026-06-30. IRD currently screens at market cap $35.7M.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
IRD currently screens at market cap $35.7M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the IRD and TDG stock pages for the full models.
Not investment advice.